Standardization of Negative Controls in Diagnostic Immunohistochemistry: Recommendations From the International Ad Hoc Expert Panel
暂无分享,去创建一个
Clive R. Taylor | Mogens Vyberg | Merdol Ibrahim | John Garratt | Paul E. Swanson | Emina E. Torlakovic | B. Gilks | P. Swanson | E. Torlakovic | G. Francis | M. Ibrahim | M. Vyberg | S. Nielsen | E. Hyjek | Blake Gilks | Rodney T. Miller | Glenn Francis | Søren Nielsen | Elizabeth Hyjek | Rodney Miller | Eugen B. Petcu | E. Petcu | John Garratt | C. Taylor
[1] C. Ball,et al. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. , 2004, The American journal of pathology.
[2] L. Bobrow,et al. Study of interlaboratory reliability and reproducibility of estrogen and progesterone receptor assays in Europe. Documentation of poor reliability and identification of insufficient microwave antigen retrieval time as a major contributory element of unreliable assays. , 2001, American journal of clinical pathology.
[3] Anthony Rhodes,et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. , 2006, Archives of pathology & laboratory medicine.
[4] C. Cheung,et al. Defining diagnostic tissue in the era of personalized medicine , 2013, Canadian Medical Association Journal.
[5] Rodney T. Miller,et al. Blocking of Endogenous Avidin-Binding Activity in Immunohistochemistry: The Use of Skim Milk as an Economical and Effective Substitute for Commercial Biotin Solutions , 1999 .
[6] W. Neuhuber,et al. Pitfalls using tyramide signal amplification (TSA) in the mouse gastrointestinal tract: Endogenous streptavidin-binding sites lead to false positive staining , 2012, Journal of Neuroscience Methods.
[7] H. Battifora,et al. The checkerboard tissue block. An improved multitissue control block. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[8] Clive R Taylor,et al. Recommendations for Improved Standardization of Immunohistochemistry , 2007, Applied immunohistochemistry & molecular morphology : AIMM.
[9] Zoltan Nusser,et al. Specificity of Immunoreactions: The Importance of Testing Specificity in Each Method , 2008, The Journal of Neuroscience.
[10] S. Hamilton,et al. POTENTIAL FALSE‐POSITIVE RESULTS WITH ANTIGEN ENHANCEMENT FOR IMMUNOHISTOCHEMISTRY OF THE p53 GENE PRODUCT IN COLORECTAL NEOPLASMS , 1996 .
[11] B. Gilks,et al. The laboratory score/reference method score ratio (LSRSR) is a novel tool for monitoring laboratory performance in immunohistochemistry proficiency testing of hormone receptors in breast cancer: the CIQC experience. , 2011, American journal of clinical pathology.
[12] C. Couture,et al. Immunohistochemistry is a Reliable Screening Tool for Identification of ALK Rearrangement in Non–Small-Cell Lung Carcinoma and is Antibody Dependent , 2013, Journal of Thoracic Oncology.
[13] Yoon-Koo Kang,et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial , 2010, The Lancet.
[14] R. Burry,et al. Specificity Controls for Immunocytochemical Methods , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[15] John M S Bartlett,et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] Clive R. Taylor,et al. Human Breast Cancer Histoid , 2011, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[17] F. Bosman,et al. Background Staining of Visualization Systems in Immunohistochemistry: Comparison of the Avidin-Biotin Complex System and the EnVision+ System , 2007, Applied immunohistochemistry & molecular morphology : AIMM.
[18] Yuval Kluger,et al. A Tissue Quality Index – an Intrinsic Control for Measurement of Effects of Pre-analytical Variables on FFPE Tissue , 2014, Laboratory Investigation.
[19] H. Kliman,et al. A mucin-like glycoprotein identified by MAG (mouse ascites Golgi) antibodies. Menstrual cycle-dependent localization in human endometrium. , 1995, The American journal of pathology.
[20] R. Goudie. Immunomicroscopy: A Diagnostic Tool for the Surgical Pathologist , 1988 .
[21] H. Dosaka-akita,et al. Method for the validation of immunohistochemical staining using SCID mouse xenografts: Expression of CD40 and CD154 in human non-small cell lung cancer , 2013, Oncology reports.
[22] R M Levenson,et al. Quantification of immunohistochemistry—issues concerning methods, utility and semiquantitative assessment II , 2006, Histopathology.
[23] C. Cordon-Cardo,et al. Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. , 1990, Oncogene.
[24] E. Luther,et al. Experimental Validation of Peptide Immunohistochemistry Controls , 2009, Applied immunohistochemistry & molecular morphology : AIMM.
[25] R. Cote,et al. Antigen Retrieval Immunohistochemistry: Past, Present, and Future , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[26] T. Vahlberg,et al. Prognostic evaluation of COX-2 expression in renal cell carcinoma. , 2010, Anticancer research.
[27] Rhona J. Souers,et al. Laboratory compliance with the American Society of Clinical Oncology/College of American Pathologists human epidermal growth factor receptor 2 testing guidelines: a 3-year comparison of validation procedures. , 2014, Archives of pathology & laboratory medicine.
[28] P. Musto,et al. Validation of vacuum-based refrigerated system for biobanking tissue preservation: analysis of cellular morphology, protein stability, and RNA quality. , 2014, Biopreservation and biobanking.
[29] K. Becker,et al. “Liquid Morphology”: Immunochemical Analysis of Proteins Extracted From Formalin-fixed Paraffin-embedded Tissues Combining Proteomics With Immunohistochemistry , 2011, Applied immunohistochemistry & molecular morphology : AIMM.
[30] S. Mills,et al. Consensual interpretive guidelines for diagnostic immunohistochemistry. , 2001, The American journal of surgical pathology.
[31] B. Gilks,et al. Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee/Immunohistochemistry: best practice recommendations for standardization of immunohistochemistry tests. , 2010, American journal of clinical pathology.
[32] J. Papadimitriou,et al. The total test approach to standardization of immunohistochemistry. , 2009, Archives of pathology & laboratory medicine.
[33] Clive R. Taylor,et al. Standardization of Immunohistochemistry for Formalin-fixed, Paraffin-embedded Tissue Sections Based on the Antigen-retrieval Technique: From Experiments to Hypothesis , 2007, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[34] Clive R Taylor,et al. Practicing Pathology in the Era of Big Data and Personalized Medicine , 2014, Applied immunohistochemistry & molecular morphology : AIMM.
[35] M. Raffeld,et al. Avidin-biotin labeling of cellular antigens in cryostat-sectioned tissue. , 1994, Methods in molecular biology.
[36] J A Ramos-Vara,et al. When Tissue Antigens and Antibodies Get Along , 2014, Veterinary pathology.
[37] José A. Ramos-Vara,et al. Suggested Guidelines for Immunohistochemical Techniques in Veterinary Diagnostic Laboratories , 2008, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.
[38] B. Clarke,et al. Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee for High Complexity Testing/Immunohistochemistry: guidelines for the preparation, release, and storage of unstained archived diagnostic tissue sections for immunohistochemistry. , 2014, American journal of clinical pathology.
[39] M. Papotti,et al. Retrieved endogenous biotin: a novel marker and a potential pitfall in diagnostic immunohistochemistry , 1997, Histopathology.
[40] S. Spicer,et al. Some ascites monoclonal antibody preparations contain contaminants that bind to selected Golgi zones or mast cells. , 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[41] Erwin G. Van Meir,et al. PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma. , 2005, Cancer research.
[42] B. Jasani,et al. A formalin-fixed, paraffin-processed cell line standard for quality control of immunohistochemical assay of HER-2/neu expression in breast cancer. , 2002, American journal of clinical pathology.
[43] Matt van de Rijn,et al. Tissue Microarrays Are an Effective Quality Assurance Tool for Diagnostic Immunohistochemistry , 2002, Modern Pathology.
[44] P. Sloan,et al. CD30-Positive T-Cell Lymphoproliferative Disorder of the Oral Mucosa—An Indolent Lesion: Report of 4 Cases , 2008, International journal of surgical pathology.
[45] Ines Gloeckner. Immunohistopathology A Practical Approach To Diagnosis , 2016 .
[46] R. Walker,et al. Quantification of immunohistochemistry—issues concerning methods, utility and semiquantitative assessment I , 2006, Histopathology.
[47] M. Ingram,et al. Tissue engineered tumor models , 2010, Biotechnic & histochemistry : official publication of the Biological Stain Commission.
[48] H. Battifora. The multitumor (sausage) tissue block: novel method for immunohistochemical antibody testing. , 1986, Laboratory investigation; a journal of technical methods and pathology.
[49] G. Bussolati,et al. Technical pitfalls potentially affecting diagnoses in immunohistochemistry , 2008, Journal of Clinical Pathology.
[50] B. Blencowe,et al. Canadian Anaplastic Lymphoma Kinase Study: A Model for Multicenter Standardization and Optimization of ALK Testing in Lung Cancer , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[51] Christopher Otis,et al. Quality assurance for design control and implementation of immunohistochemistry assays; Approved guidelinesecond edition , 2011 .
[52] Rodney T. Miller,et al. Blocking of Endogenous Avidin-Binding Activity in Immunohistochemistry: The Use of Egg Whites , 1997 .
[53] W. Fu,et al. Using protein microarray technology to screen anti-ERCC1 monoclonal antibodies for specificity and applications in pathology , 2012, BMC Biotechnology.
[54] Clive R. Taylor,et al. Standardization of immunohistochemistry based on antigen retrieval technique for routine formalin-fixed tissue sections , 1998 .
[55] B. Jasani,et al. Potential for false-positive staining with a rabbit monoclonal antibody to progesterone receptor (SP2): findings of the UK National External Quality Assessment Scheme for Immunocytochemistry and FISH highlight the need for correct validation of antibodies on introduction to the laboratory. , 2008, American journal of clinical pathology.
[56] Linda A Bradley,et al. Principles of analytic validation of immunohistochemical assays: Guideline from the College of American Pathologists Pathology and Laboratory Quality Center. , 2014, Archives of pathology & laboratory medicine.
[57] S. Shi,et al. Chapter 1 – Techniques of Immunohistochemistry: Principles, Pitfalls and Standardization , 2006 .
[58] C. Taylor. Quantifiable internal reference standards for immunohistochemistry: the measurement of quantity by weight. , 2006, Applied immunohistochemistry & molecular morphology : AIMM.
[59] M. Kojima,et al. Optimal fixation for total preanalytic phase evaluation in pathology laboratories. A comprehensive study including immunohistochemistry, DNA, and mRNA assays , 2014, Pathology international.
[60] T J O'Leary,et al. Standardization in Immunohistochemistry , 2001, Applied immunohistochemistry & molecular morphology : AIMM.
[61] A. Paetau,et al. ERG Transcription Factor as an Immunohistochemical Marker for Vascular Endothelial Tumors and Prostatic Carcinoma , 2011, The American journal of surgical pathology.
[62] Mike Clarke,et al. Tamoxifen for early breast cancer: an overview of the randomised trials , 1998, The Lancet.
[63] W. D. den Dunnen,et al. Solvent‐free tissue processing using supercritical carbon dioxide , 2012, Histopathology.
[64] P. Tan,et al. Hormone receptor expression in breast cancer: postanalytical issues , 2013, Journal of Clinical Pathology.
[65] Anthony Rhodes,et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. , 2010, Archives of pathology & laboratory medicine.